120 related articles for article (PubMed ID: 20200944)
1. Gs G protein-coupled receptor signaling in osteoblasts elicits age-dependent effects on bone formation.
Hsiao EC; Boudignon BM; Halloran BP; Nissenson RA; Conklin BR
J Bone Miner Res; 2010 Mar; 25(3):584-93. PubMed ID: 20200944
[TBL] [Abstract][Full Text] [Related]
2. Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formation.
Hsiao EC; Millard SM; Louie A; Huang Y; Conklin BR; Nissenson RA
Mol Endocrinol; 2010 Mar; 24(3):621-31. PubMed ID: 20150184
[TBL] [Abstract][Full Text] [Related]
3. Assessing the osteoblast transcriptome in a model of enhanced bone formation due to constitutive Gs-G protein signaling in osteoblasts.
Wattanachanya L; Wang L; Millard SM; Lu WD; O'Carroll D; Hsiao EC; Conklin BR; Nissenson RA
Exp Cell Res; 2015 May; 333(2):289-302. PubMed ID: 25704759
[TBL] [Abstract][Full Text] [Related]
4. Increased Gs Signaling in Osteoblasts Reduces Bone Marrow and Whole-Body Adiposity in Male Mice.
Cain CJ; Valencia JT; Ho S; Jordan K; Mattingly A; Morales BM; Hsiao EC
Endocrinology; 2016 Apr; 157(4):1481-94. PubMed ID: 26901092
[TBL] [Abstract][Full Text] [Related]
5. Loss of Gi G-Protein-Coupled Receptor Signaling in Osteoblasts Accelerates Bone Fracture Healing.
Wang L; Hsiao EC; Lieu S; Scott M; O'Carroll D; Urrutia A; Conklin BR; Colnot C; Nissenson RA
J Bone Miner Res; 2015 Oct; 30(10):1896-904. PubMed ID: 25917236
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass.
Hsiao EC; Boudignon BM; Chang WC; Bencsik M; Peng J; Nguyen TD; Manalac C; Halloran BP; Conklin BR; Nissenson RA
Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1209-14. PubMed ID: 18212126
[TBL] [Abstract][Full Text] [Related]
7. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
Wang L; Liu S; Quarles LD; Spurney RF
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
[TBL] [Abstract][Full Text] [Related]
8. Mineral composition is altered by osteoblast expression of an engineered G(s)-coupled receptor.
Kazakia GJ; Speer D; Shanbhag S; Majumdar S; Conklin BR; Nissenson RA; Hsiao EC
Calcif Tissue Int; 2011 Jul; 89(1):10-20. PubMed ID: 21526395
[TBL] [Abstract][Full Text] [Related]
9. Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia.
Peng J; Bencsik M; Louie A; Lu W; Millard S; Nguyen P; Burghardt A; Majumdar S; Wronski TJ; Halloran B; Conklin BR; Nissenson RA
Endocrinology; 2008 Mar; 149(3):1329-37. PubMed ID: 18048501
[TBL] [Abstract][Full Text] [Related]
10. Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation.
Millard SM; Louie AM; Wattanachanya L; Wronski TJ; Conklin BR; Nissenson RA
J Bone Miner Res; 2011 Apr; 26(4):822-32. PubMed ID: 20939063
[TBL] [Abstract][Full Text] [Related]
11. Disrupted bone remodeling leads to cochlear overgrowth and hearing loss in a mouse model of fibrous dysplasia.
Akil O; Hall-Glenn F; Chang J; Li A; Chang W; Lustig LR; Alliston T; Hsiao EC
PLoS One; 2014; 9(5):e94989. PubMed ID: 24788917
[TBL] [Abstract][Full Text] [Related]
12. Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone.
Lung H; Wentworth KL; Moody T; Zamarioli A; Ram A; Ganesh G; Kang M; Ho S; Hsiao EC
JBMR Plus; 2024 May; 8(5):ziae011. PubMed ID: 38577521
[TBL] [Abstract][Full Text] [Related]
13. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
Wang L; Quarles LD; Spurney RF
J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5.
Rutter MM; Markoff E; Clayton L; Akeno N; Zhao G; Clemens TL; Chernausek SD
Bone; 2005 Feb; 36(2):224-31. PubMed ID: 15780948
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass.
Nakanishi R; Akiyama H; Kimura H; Otsuki B; Shimizu M; Tsuboyama T; Nakamura T
J Bone Miner Res; 2008 Feb; 23(2):271-7. PubMed ID: 17907918
[TBL] [Abstract][Full Text] [Related]
16. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
17. The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice.
Schinke T; Gebauer M; Schilling AF; Lamprianou S; Priemel M; Mueldner C; Neunaber C; Streichert T; Ignatius A; Harroch S; Amling M
Bone; 2008 Mar; 42(3):524-34. PubMed ID: 18178537
[TBL] [Abstract][Full Text] [Related]
18. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria.
de Pollak C; Arnaud E; Renier D; Marie PJ
J Cell Biochem; 1997 Jan; 64(1):128-39. PubMed ID: 9015761
[TBL] [Abstract][Full Text] [Related]
19. Role of Osteoblast Gi Signaling in Age-Related Bone Loss in Female Mice.
Millard SM; Wang L; Wattanachanya L; O'Carroll D; Fields AJ; Pang J; Kazakia G; Lotz JC; Nissenson RA
Endocrinology; 2017 Jun; 158(6):1715-1726. PubMed ID: 28407060
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
